© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Dan Wetherill
Articles
To Reduce Commercial Risk for Orphan Drugs, Transform Forecasting
To successfully commercialize orphan drugs, companies need to set aside general medicine strategies and adopt a more granular approach to identifying and capitalizing on commercial opportunities.
Data Analytics: Strength — and Solutions — in Numbers
Dan Wetherill offers three priorities for how pharma companies can better use data analytics to engage customers.